IDHC — Integrated Diagnostics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $221.10m
- $236.68m
- EGP4.12bn
- 93
- 25
- 53
- 59
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 758 | 969 | 2,232 | 854 | 737 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 29.3 | 54.7 | 54.8 | 3.12 | 61.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -244 | -327 | -256 | -965 | -656 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 697 | 883 | 2,270 | 209 | 544 |
Capital Expenditures | -218 | -126 | -264 | -309 | -326 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 81.6 | 1.74 | -1,064 | 1,299 | 82 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -136 | -124 | -1,328 | 990 | -244 |
Financing Cash Flow Items | -13.7 | -56.4 | -114 | -123 | -86 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -549 | -564 | -647 | -1,618 | -330 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.71 | 191 | 291 | -243 | 25.7 |